Harrisson S et al. Six month interim results of MSDC-0602K in a large phase 2b NASH study demonstrate significant improvement in liver enzymes and glycemic control (NCT02784444). (Abstract PS-111)
Fidaxomicine en vancomycine verlagen 'C. difficile'-uitscheiding en contaminatie van de omgeving
aug 2022 | Bacteriële infecties